Brief: RenovoRx May Offer Securities For Up To $50 Million - SEC Filing
14/11/2025 21:38
Nov 14 (Reuters) - RenovoRx Inc RNXT.O: RENOVORX INC - MAY OFFER SECURITIES FOR UP TO $50 MILLION - SEC FILING Source text: [ID:n0001493152-25-023525] Further company coverage: RNXT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on RenovoRx
See all newsBrief: Renovorx Advances Tamp Into Borderline Resectable Pancreatic Cancer With First Patient Enrolled In Investigator-Initiated Prism-Tamp Trial
RenovoRx Inc reports results for the quarter ended June 30 - Earnings Summary
Oncology device maker RenovoRx's Q2 revenue surges, raises FY outlook
Brief: RenovoRx Q2 Net Income USD -2.911 Million
Brief: Renovorx Achieves Major Milestone With Full Enrollment In Phase Iii Tiger-Pac Trial For Locally Advanced Pancreatic Cancer